These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: role of nuclear factor kappa B and interferon regulatory factor 1. Hecker M; Preiss C; Klemm P; Busse R Br J Pharmacol; 1996 Aug; 118(8):2178-84. PubMed ID: 8864559 [TBL] [Abstract][Full Text] [Related]
3. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP. Boese M; Busse R; Mülsch A; Schini-Kerth V Br J Pharmacol; 1996 Oct; 119(4):707-15. PubMed ID: 8904645 [TBL] [Abstract][Full Text] [Related]
4. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta. Hecker M; Preiss C; Schini-Kerth VB Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219 [TBL] [Abstract][Full Text] [Related]
5. N-alpha-tosyl-L-lysine chloromethylketone prevents expression of iNOS in vascular smooth muscle by blocking activation of NF-kappa B. Schini-Kerth VB; Boese M; Busse R; Fisslthaler B; Mülsch A Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):672-9. PubMed ID: 9108779 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. Hattori Y; Hattori S; Kasai K Eur J Pharmacol; 2003 Nov; 481(2-3):153-8. PubMed ID: 14642780 [TBL] [Abstract][Full Text] [Related]